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Abstract
Background: Streptococcus pneumoniae is a leading cause of invasive bacterial disease in developed and developing
countries. We studied the loop-mediated isothermal amplification (LAMP) technique to assess its suitability for detecting
S. pneumoniae nucleic acid in cerebrospinal fluid (CSF).
Methodology/Principal Findings: We established an improved LAMP assay targeting the lytA gene (Streptococcus
pneumoniae [Sp] LAMP). The analytical specificity of the primers was validated by using 32 reference strains (10
Streptococcus and seven non-Streptococcus species) plus 25 clinical alpha-hemolytic streptococcal strains, including four
S. pneumoniae strains and 21 other strains (3 S. oralis, 17 S. mitis, and one Streptococcus species) harboring virulence factor-
encoding genes (lytA or ply). Within 30 minutes, the assay could detect as few as 10 copies of both purified DNA and spiked
CSF specimens with greater sensitivity than conventional polymerase chain reaction (PCR). The linear determination range
for this assay is 10 to 1,000,000 microorganisms per reaction mixture using real-time turbidimetry. We evaluated the clinical
sensitivity and specificity of the Sp LAMP assay using 106 randomly selected CSF specimens from children with suspected
meningitis in Korea, China and Vietnam. For comparison, CSF specimens were also tested against conventional PCR and
culture tests. The detection rate of the LAMP method was substantially higher than the rates of PCR and culture tests. In this
small sample, relative to the LAMP assay, the clinical sensitivity of PCR and culture tests was 54.5% and 33.3%, respectively,
while clinical specificity of the two tests was 100%.
Conclusions/Significance: Compared to PCR, Sp LAMP detected S. pneumoniae with higher analytical and clinical sensitivity.
This specific and sensitive LAMP method offers significant advantages for screening patients on a population basis and for
diagnosis in clinical settings.
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Introduction
Streptococcus pneumoniae is associated with invasive and non-
invasive diseases, such as meningitis, bacteremia, septicemia,
community-acquired pneumonia, and otitis media [1]. Each year,
approximately 875,000 children die as a result of pneumococcal
disease, with most deaths occurring in developing countries [2].
Elderly persons and immunocompromised hosts (including
patients with HIV infection, sickle-cell anemia and other chronic
diseases) also bear a substantial burden of pneumococcal disease in
developed and developing countries [1]. Although traditional
antimicrobial therapy has proven to be effective, pneumococcal
resistance to essential antimicrobials has increased rapidly in
recent decades and poses a serious global problem [3].
For several decades, diagnosis of pneumococcal infection has
relied on classic bacterial culture and identification methods.
However, isolation and identification of pneumococcus are
complicated by contamination with alpha-hemolytic streptococci
(S. mitis and S. oralis) belonging to normal human flora. S. mitis and
S. oralis are most closely related to pneumococcus on this ecological
basis, and their 16S rRNA sequences share over 99% identity with
pneumococcus, which presents a challenge for clinical laboratories
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to differentiate pneumococcus from other alpha-hemolytic oral
streptococci [4]. Such misidentification might affect diagnosis and
treatment. In developing countries, accurate diagnosis of pneu-
mococcus remains a challenge due to the limited availability of
routine microbiology laboratory services and injudicious use of
antimicrobial agents.
Molecular assays are inherently valuable because of their
enhanced analytical and clinical sensitivity and specificity. Such
assays also have the potential to provide a diagnosis by detecting
nonviable organisms in patients who have received antibiotic
treatment [5,6,7]. The development of PCR assays that target
ply [5] and lytA (Sp PCR) [6] genes was an important milestone in
the evolution of laboratory diagnosis of pneumococcus. However,
the ply and lytA genes, initially thought to be present only in S.
pneumoniae, were recently reported in strains of S. mitis [4]. Thus,
PCR-based detection that targets those genes might result in over-
detection of pneumococcus [8]. A real-time PCR method that
targets the lytA gene was reported to be sensitive and specific for
detecting S. pneumoniae [9]. However, PCR and real-time PCR
equipment is relatively expensive, and the assays are complex to
perform in resource-limited laboratories in developing countries.
Detection of S. pneumoniae teichoic acid antigen in urine (Binax
NOWH S. pneumoniae, Alere International Limited, Galway,
Ireland) is an alternative to culture or PCR; however, its specificity
is low in children because it can give positive results in healthy
children who carry pneumococci and other closely related
Streptococcus species [10].
In 2000, a novel nucleic acid detection method, loop-mediated
isothermal amplification (LAMP), was first reported by Notomi
and colleagues [11]. LAMP employs a DNA polymerase with
strand-displacement activity, along with two inner primers (for-
ward inner primer, FIP; backward inner primer, BIP) and two
outer primers (F3, B3) that recognize six separate regions within
a target DNA sequence. This method utilizes a unique priming
mechanism that yields specific DNA products in a shorter time
than PCR. Additional primers (i.e., the so-called loop primers:
loop-primer forward, LF; loop-primer backward, LB) designed to
anneal the loop structure in LAMP can be used to accelerate the
LAMP reaction resulting in enhanced sensitivity [12]. The loop
primers are now commonly used in practical applications of
LAMP [13]. Although LAMP assays for detecting pneumococcus
in oral bacteria have been established [14], their efficacy in
diagnosing bacterial meningitis has not yet been tested [15].
In this study, we established an improved LAMP assay by
adding a loop primer targeting the lytA gene (Sp LAMP), and we
compared the detection performance of the Sp LAMP assay with
that of Sp PCR by using cerebrospinal fluid (CSF) specimens from
patients with suspected meningitis in Korea, China and Vietnam
[16]. To our knowledge, this is the first report of using a LAMP
assay for detecting S. pneumoniae in clinical CSF specimens.
Methods
Ethics Statement
To analyze the specimens in this study, we utilized CSF
specimens preserved from our previous surveillance study [16]. All
CSF specimens utilized in this study were de-identified prior to
laboratory processing and analysis. Ethical approvals for patient
specimen collection during surveillance were obtained from the
following institutions: International Vaccine Institute, Seoul,
Korea; Harbor UCLA Medical Center, Torrance, CA, USA;
Chonbuk National University Hospital, Jeonju, Korea; Chonju
Presbyterian Hospital, Jeonju, Korea; Namwon Medical Center,
Namwon, Korea; Jeongeub Asan Foundation Hospital, Jeongeub,
Korea; Won Kwan University Hospital, Iksan, Korea; National
Institute of Hygiene and Epidemiology, Hanoi, Vietnam; National
Institute of Pediatrics, Hanoi, Vietnam; St. Paul Hospital, Hanoi,
Vietnam; Bach Mai Hospital, Hanoi, Vietnam; and the Guangxi
Zhuang Autonomous Region Center for Disease Control,
Nanning, China. Each institution participated in prospective,
population-based surveillance for childhood meningitis from 1999
to 2002. During those surveillance studies, written consent was not
obtained as the collection of CSF was considered routine standard
care for hospitalized children with suspected bacterial meningitis.
For this reason, verbal consent of the parent or legal guardian
present with the child during the hospitalization was recorded in
the patient’s medical chart at the time of the clinical lumbar
puncture procedure. This consenting procedure was approved by
the local scientific ethics review committees of participating
institutions.
Clinical CSF Specimens
Children with suspected meningitis who were less than five
years old were prospectively enrolled at study hospitals [16].
Clinicians classified patients as having suspected, probable or
confirmed bacterial meningitis based on clinical signs and
symptoms, CSF parameters (e.g., white blood cell count, glucose
and protein levels) and bacterial testing (i.e., culture and latex
agglutination testing). CSF was streaked on commercial blood agar
culture medium (Becton, Dickinson & Co., Franklin Lakes, NJ,
USA) and incubated in 5% CO2 at 37uC for 3 days and checked
daily for growth in the previous study [16]. Isolates were identified
using standard microbiological criteria [17]. To compare pneu-
mococcal detection by PCR and LAMP, 106 CSF specimens
(18 Sp PCR-positive and 88 Sp PCR-negative) were randomly
selected from CSF collected between 1998 and 2002 in the
prospective study [16] of bacterial meningitis in Korea (n= 40),
China (n= 33) and Vietnam (n= 33). CSF specimens were
pretreated at 95uC for 2 min and centrifuged (13,0006g, 5 min).
The supernatant was saved for Sp PCR and Sp LAMP analysis. Sp
PCR was performed as described previously [7]. A 5-ml aliquot (a
sample volume consistent with future clinical applications) from
each CSF specimen was subjected to Sp PCR (25-ml reaction
volume) and Sp LAMP, as described below.
Bacterial Strains
Overall, 32 standard reference strains representing 10 Strepto-
coccus species and seven non-Streptococcus species were evaluated.
Among the seven non-Streptococcus species were Haemophilus
influenzae (RD), Escherichia coli (DH5a), Actinobacillus actinomycetemco-
mitans (Y-4), Porphyromonas gingivalis (381, ATCC49417,
ATCC33277), Actinomyces naeslundii (WVU627, T14,
ATCC12104), Prevotella intermedia (ATCC25611), and P. nigrescens
(ATCC25261). The 10 Streptococcus species were Streptococcus mitis
(ATCC903), S. oralis (ATCC9811, 10557), S. gordonii
(ATCC12396), S. agalactiae (IID1625), S. milleri (NCTC10703),
S. sobrinus (NIDR6715, OMZ176), S. mutans (XC47, PK1, JC2),
S. sanguis (ATCC10556), S. salivarius (ATCC7073, ATCC9222,
HHT), and S. pneumoniae (R6, ATCC6305, GTC261, IID553,
IID554). In addition, 25 clinical alpha-hemolytic streptococcal
strains were evaluated, including four S. pneumoniae strains and 21
other Streptococcus species (three S. oralis, 17 S. mitis, and one
Streptococcus species) known to carry the ply and lytA genes [14].
Preparation of Chromosomal DNA
Genomic DNA was purified from the 57 strains above using
a QIAamp DNA mini kit (QIAGEN, Valencia, CA) according to
the manufacturer’s protocol. For the detection limit analysis,
Pneumococcal LAMP Assay for Meningitis
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genomic DNA from S. pneumoniae ATCC 6305 was obtained as
previously described, and the concentration was determined using
an Ultrospec 3300 Pro spectrophotometer (Amersham Pharmacia
Biotech, Cambridge, UK). The number of genome copies was
calculated based on the known genome molecular size (2.04 Mbp)
of S. pneumoniae R6 (accession number AE007317). To ascertain
the detection limit of the Sp LAMP assay, serial ten-fold dilutions
of genomic DNA were amplified, and the results were compared
with those obtained using conventional Sp PCR.
For the detection limit study, triplicate Sp LAMP testing was
performed over 3 days using the ten-fold dilutions of genomic
DNA. Two technicians independently tested the same samples to
confirm the reproducibility of Sp LAMP results. The supernatant
of a pooled pneumococcus-negative CSF specimen [16] was used
for a spiking assay in which serial ten-fold dilutions of genomic
DNA were amplified, and the results were compared between Sp
LAMP and conventional Sp PCR.
Sp LAMP Primer Design
We designed a loop primer using LAMP primer support
software (Net Laboratory, Kanagawa, Japan) based on published
sequences of the lytA gene of a S. pneumoniae strain (GenBank
accession number: AE008540) [14]. As described previously [14],
we compared the lytA sequences of four S. pneumoniae strains
(GenBank accession numbers: AE008540, AE007483, M13812
and AF467249) and nine other organisms that harbor the lytA
gene, namely, Streptococcus mitis lytA (GenBank accession number:
AJ617815 and AJ617816) and Streptococcus species lytA (GenBank
accession numbers: AJ252190, AJ252191, AJ252192, AJ252193,
AJ252194, AJ252195 and AJ252196). The consensus sequence
among the S. pneumoniae strains was determined (Fig. 1), and
S. pneumoniae-specific LAMP primers, specifically F3, B3, FIP, BIP,
and LB (Fig. 1), were designed after the alignment analysis.
Sp LAMP Reaction
The reaction mixture (25 mL) contained 1.6 mM each of FIP
and BIP, 0.2 mM each of F3 and B3, 0.4 mM of LB, 8 U of Bst
DNA polymerase large fragment (New England Biolabs, Ipswich,
MA, USA), 1.4 mM deoxynucleoside triphosphates, 0.8 M
betaine (Sigma, St. Louis, MO, USA), 20 mM Tris-HCl (pH
8.8), 10 mM KCl, 10 mM (NH4)2SO4, 8 mM MgSO4, 0.1%
Tween 20, and template DNA (2 mL, for analytical determination
purposes). The mixture was incubated at 63uC for either 35 or
60 minutes and then heated at 80uC for 2 minutes to terminate
the reaction.
Analysis of Sp LAMP Products
The LAMP reaction was evaluated by visual inspection because
the Sp LAMP reaction generates turbidity proportional to the
amount of amplified DNA [18]. Amplified products were resolved
by electrophoresis in 3% agarose gels, followed by visualization by
ethidium bromide staining. For further confirmation, a Loopamp
Figure 1. Nucleotide sequence of the lytA gene used to design the Sp LAMP primer. The sequences used for Sp LAMP primers are
indicated by arrows (A). Structure and sequence of the primers used in the Sp LAMP reaction (B).
doi:10.1371/journal.pone.0042954.g001
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real-time turbidimeter (LA-200; Teramecs, Kyoto, Japan) moni-
tored the turbidity in the reaction tube in real time by reading the
OD650 every 6 seconds. The presence of a greater quantity of
initial template DNA shortened the threshold time to detection of
S. pneumoniae. We used the application software for the turbidim-
eter to obtain the amplification time required to exceed the
turbidity level of 0.1 (Tt), according to the manufacturers’ protocol
[18].
To confirm the fidelity of amplification, a portion of the
amplified products was digested with the restriction enzyme TasI
(Fermentas Inc., Hanover, MD, USA), and their sizes were
analyzed by electrophoresis in 3% agarose gels, followed by
ethidium bromide staining. To verify the structure of the amplified
Sp LAMP products, the amplified products were sequenced using
a BigDye Terminator V3.1 cycle sequencing kit (Applied
Biosystems, Foster City, CA, USA) and an ABI PRISM 377
DNA sequencer (Applied Biosystems) according to the manufac-
turer’s instructions. The primers used to sequence the target region
(between F1 and B1) were as follows: F2 primer, 59-CACT-
CAACTGGGAATCCGC-39, and B2 primer, 59-CCAGGCAC-
CATTATCAACAGG-39 (Fig. 1).
PCR Assay
We used the sequences of conventional Sp PCR primers
described previously for lytA [6,7]. The PCR mixture (10 ml)
consisted of 0.2 mM of each deoxyribonucleoside triphosphate,
10 mMTris-HCl buffer (pH 8.3), 50 mM KCl, 2 mM MgCl2, 1 U
of Ex Taq DNA polymerase (TaKaRa Bio Inc., Otsu, Japan),
0.5 mM concentrations of each primer and 1 ml of template DNA
(sample volume was chosen for analytical determination purposes).
PCRwas performed using a thermal cycler (MJResearch,Waltham,
MA,USA) for 30 cycles. Each cycle consisted of 15 s at 94uC, 15 s at
53uC, and 15 s at 72uC. Products were visualized by resolution on
a 2% agarose gel followed by staining with ethidium bromide.
Statistical Analysis
The clinical sensitivity and specificity of conventional Sp PCR
and culture testing were compared to those of Sp LAMP (the gold
Figure 2. Real-time sensitivity of Sp LAMP, as monitored by the measurement of turbidity. Shown from left to right in the figure are the
curves of decreasing concentration (1,000,000 to 1) of bacteria. The detection limit was 10 copies (A). The relationship between the threshold time (Tt)
of each sample and the log of the amount of initial template DNA (B).
doi:10.1371/journal.pone.0042954.g002
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standard was Sp LAMP results). A linear regression line was
obtained by plotting the amplification time required to exceed the
turbidity level of 0.1 (Tt) against the log of the initial template
DNA.
Results and Discussion
To develop a more rapid and sensitive Sp LAMP reaction, we
substantially refined our previously reported Sp LAMP assay [14]
by adding another loop primer (loop primer backward). With the
addition of this primer, the Sp LAMP assay successfully amplified
the 194-bp target sequence of the lytA gene locus within 30 min
(previously 60 min [12]) (Fig. 2). The product was visible on an
agarose gel (Fig. 3). The amplified product had a ladder-like
pattern on the gel that is characteristic of the LAMP reaction and
indicates the production of stem-loop DNAs with inverted repeats
of the target sequence [11].
Analytical Specificity of Sp LAMP
To evaluate the species specificity of the Sp LAMP primers, we
tested 32 reference strains and 25 clinical alpha-hemolytic
streptococcal strains, including four S. pneumoniae strains and 21
other Streptococcus species (three S. oralis, 17 S. mitis, and one
Streptococcus species) known to carry the ply and lytA genes (Table 1).
For each assay mixture, a standard genomic DNA concentration
(106 copies) was used for each strain. In the Sp LAMP reaction,
amplification of pneumococcal DNA was observed after 35 min-
utes. In contrast, genomic DNA of non-pneumococcal strains was
not amplified even after 60 minutes of incubation, whereas PCR
produced four false-positive results for lytA and 17 false-positive
results for ply in 25 clinical streptococcal strains (Table 1).
Amplification specificity was confirmed by TasI digestion to
ensure that the product contained sequences corresponding to the
selected target gene sequence of the pneumococcus lytA gene locus.
The products of TasI digestion were 107 and 108 bp, which is
consistent with the predicted sizes (Fig. 3). Amplified products
were further analyzed by sequencing, and the sequences were
compared with those of the targeted region (bases 133 to 154 in
the original sequence) of the pneumococcus lytA gene (between F1
and B1; Fig. 1). The sequences obtained were identical to the
expected nucleotide sequences (data not shown). The Sp LAMP
assay used in this study was more analytically specific than Sp
PCR. Because the amplification reaction occurs only when all
seven regions within a target DNA (Fig. 1) are correctly recognized
by the primers [13], the Sp LAMP assay has high specificity. The
higher analytical specificity of the Sp LAMP assay is in agreement
with our previous findings [14,19]. To improve the specificity of
the LAMP reaction, it is important to locate more specific
sequences within primer regions. Several primer sets were
designed and tested for detection limit and analytical specificity
Figure 3. Electrophoretic analysis of Sp LAMP-amplified
products. Lane M, 100-bp ladder (New England Biolabs, Beverly, MA,
USA) used as a size marker; lane 1, Sp LAMP product from lane 2 after
digestion with TasI (Fermentas, Inc.). The digested fragments were 107
and 108 bp; lane 2, 106 copies of the genomic DNA of S. pneumoniae
ATCC 6305; lane 3, no template.
doi:10.1371/journal.pone.0042954.g003
Table 1. Detection of S. pneumoniae in 25 clinical isolates of oral streptococci by PCR and LAMP methods.




1, 2 S. oralis 2 + S. oralis + 2 2
3 S. oralis 2 2 S. oralis + 2 2
4 to 14 S. mitis 2 + S. mitis + 2 2
15 to 17 S. mitis 2 2 S. mitis + 2 2
18 S. mitis 2 + S. mitis 2 + 2
19, 20 S. mitis 2 2 S. mitis 2 + 2
21 Not identified 2 2 Streptococcus species 2 + 2
22 to 25 S. pneumonia + + S. pneumoniae + + +
aClassification based on API20 Strep identification testing.
b+, optochin sensitive; 2, optochin resistant.
c+, bile soluble; 2, bile insoluble.
dFinal identification from API20 strep testing, optochin sensitivity and bile solubility.
e+, amplification occurred; 2, amplification did not occur.
doi:10.1371/journal.pone.0042954.t001
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by using reference DNA in optimal conditions, and the primer set
described herein showed the best results.
Detection Limit of the Sp LAMP Assay
Serial ten-fold dilutions of genomic pneumococcal DNA were
reliably amplified at a lower limit of 10 genome copies per reaction
(triplicate trial) (Table 2). In contrast, Sp PCR had a detection
limit of 104 (Table 2) genome copies per reaction. The detection
limit of the Sp LAMP assay was identical when measured by the
Loopamp real-time turbidimeter, direct visual inspection or gel
electrophoresis (Table 2, Fig. 2A). Similarly, using spiked CSF
specimens, the detection limit of the Sp LAMP assay was 10
genome copies and was 104 genome copies for Sp PCR (Table 3).
Overall, the detection limit of the Sp LAMP assay was 1,000 times
lower than that of Sp PCR. No amplification was apparent in the
Sp LAMP reaction when the sample tube lacked target DNA.
Identical results were replicated in a triplicate experiment
conducted over three days by two independent laboratory
technicians.
Previous studies using the same Sp PCR assay and a real-time
PCR assay that target the lytA gene were reported to have
detection limits around 50 [20] and 22 copies [9] per reaction,
respectively. The Sp LAMP assay (detection limit, 10 copies) was
more sensitive than either conventional or real-time PCR. The
lower detection limit of the Sp LAMP assay is in agreement with
our previous findings [14,19].
Real-time Turbidity Measurement
As the LAMP reaction progresses, it generates pyrophosphate
ions that bind to magnesium ions to form a white precipitate of
magnesium pyrophosphate. The resulting turbidity is readily
assessed by direct visual inspection. This characteristic feature of
the LAMP reaction can be used to evaluate the reaction end-point
simply by observing the presence of precipitate. Real-time
turbidity measurements of the LAMP reaction [16] permit
quantitative detection of minute amounts of nucleic acids with
high precision and over a wide range. In the present study, using
that apparatus, the curve of real-time turbidity measurements had
high linearity from 10 to 106 copies of S. pneumoniae template DNA
with an excellent correlation coefficient (r2 = 0.999, Fig. 2B). This
observation indicates that the concentration of any template DNA
can be determined by comparing the Tt value with the Tt values of
template DNA samples of known concentrations. Thus, when
a real-time turbidity monitoring system is used, the concentrations
of pneumococcal DNA in clinical samples can be quantified.
Sp LAMP and Sp PCR Analysis of CSF Specimens
We tested 106 CSF specimens by Sp LAMP and Sp PCR
assays. Among 33 Sp LAMP-positive specimens, 18 (54.5%) were
Sp PCR positive and 15 were Sp PCR negative, and 11 CSF
specimens were S. pneumoniae culture positive (33.3%) (Table 4). In
addition, 73 Sp LAMP-negative specimens (100%) were also
negative by Sp PCR and culture methods (Table 4). All 11 S.
pneumoniae culture-positive specimens (100%) were positive by both
Sp LAMP and Sp PCR assays.
Gram-positive cocci consistent with S. pneumoniae were identified
by gram stain in 16 CSF specimens. Of these, 10 were positive by
pneumococcal culture, Sp PCR and Sp LAMP; five were negative
by pneumococcal culture, Sp PCR and Sp LAMP (including three
Streptococcus agalactiae culture-positive and two coagulase-negative
Staphylococcus culture-positive specimens); and one CSF specimen
was negative by pneumococcal culture and Sp PCR but positive
by Sp LAMP. The original culture of this CSF specimen showed
positive growth, but the organism was not identified. Thus, it
seems the lower detection limit of the Sp LAMP reaction affected
this result.
We confirmed, by sequencing and digestion with TasI, that all
of the Sp LAMP reaction products for CSF corresponded to the
selected gene target (New England Biolabs, data not shown).
Compared with Sp LAMP, the clinical sensitivity of Sp PCR and
Table 2. Detection limits of the LAMP and PCR assays for Streptococcus pneumoniae.
Assay S. pneumoniae genome copy number
a
106 105 104 103 102 10 1 0
Sp PCRb + + + 2 2 2 2 2
Sp LAMP, 35 minc + + + + + + 2 2
Sp LAMP, 60 minc + + + + + + 2 2
aResults obtained by triplicate trial: +, amplification occurred; 2, amplification did not occur.
bResults obtained by electrophoretic analysis.
cResults determined by visual inspection.
doi:10.1371/journal.pone.0042954.t002
Table 3. Detection limit of the LAMP and PCR assays using cerebrospinal fluid specimens spiked with S. pneumoniae (ATCC 6305).
Assay S. pneumoniae genome copy number
a
106 105 104 103 102 10 1 0
Sp PCRb + + + 2 2 2 2 2
Sp LAMP, 60 minc + + + + + + 2 2
aResults obtained by duplicate trial: +, amplification occurred; 2, amplification did not occur.
bResults obtained by electrophoretic analysis.
cResults determined by visual inspection.
doi:10.1371/journal.pone.0042954.t003
Pneumococcal LAMP Assay for Meningitis
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culture tests was 54.5% and 33.3%, respectively; and the clinical
specificity of the two tests was 100%. Thus, the Sp LAMP assay
was more sensitive than the Sp PCR and culture methods.
In our analysis, the observation that 23% (22/95) of the culture-
negative CSF specimens and 17% (15/88) of the Sp PCR-negative
CSF specimens were Sp LAMP-positive. From a clinical view-
point, the excellent clinical sensitivity and specificity of the Sp
LAMP assay will be valuable to confirm and exclude the presence
of pneumococcal infection [21]. More accurate diagnosis of S.
pneumoniae infection obtained using this Sp LAMP assay could
improve the use of antibiotics and reduce currently high levels of
antibiotic resistance. From a public health standpoint, widespread
application use of the Sp LAMP assay may could yield higher
detection rates and alter global pneumococcal prevalence rates in
the future.
Our results showing higher clinical sensitivity of the Sp LAMP
assay are consistent with results of the LAMP assay developed for
detecting H. influenzae type b in CSF [19]. Previous studies
demonstrated that the LAMP reaction is more tolerant of
potentially perturbing biological substances than PCR [22]. In
the present study, the detection limit for PCR assays, using spiked
CSF specimens (Table 3), was the same as that obtained using
purified S. pneumoniae DNA (Table 2). Thus, the PCR assays we
used seemed to be well optimized for clinical CSF specimen testing
and were minimally perturbed by biological substances. Overall,
the main reason for higher clinical sensitivity of the LAMP assay
seems to be higher analytical sensitivity.
In addition, the robust performance of the LAMP assay in
previous studies [23] suggests that LAMP-based detection of
S. pneumoniae and other invasive bacterial pathogens could be
feasible in a wide variety of clinical settings. The cost (including
cost of reagents, supplies and personnel time) of performing the Sp
LAMP in our laboratory suggests that the per-specimen cost of the
LAMP assay is remarkably lower than PCR. The low technology
requirements for the LAMP assay suggest that this platform could
be particularly suitable for resource-limited settings in many
developing countries.
In conclusion, the Sp LAMP assay established in this study has
a detection limit more sensitive than those previously described for
Sp PCR methods, using both purified DNA and DNA-spiked
CSF. The lower detection limit of the Sp LAMP assay yielded
a higher detection rate for CSF specimens compared to the Sp
PCR assay. Further evaluation of the Sp LAMP in prospective
studies is now underway to confirm the Sp LAMP test’s
characteristics, including clinical sensitivity, clinical specificity,
predictive values and likelihood ratios compared with bacterial
culture, antigen detection and PCR.
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